Pitogo, Regin S.
HRN: 21-66-36 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/04/2022
07/13/2022
IV
500 Mg
TID
Infectious Diarrhea
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes